CONSOLIDATED FINANCIAL HOLDINGS LIMITED (ASX.CWL)

a loss declaration has been issued and the capital loss can therefore be claimed in the financial year the declaration is issued (this declaration was issued on 15 September 2023)

Antony Resnick and Suelen McCallum are appointed liquidators

delisted by ASX under Listing Rule 17.12

we understand ASX removed the company from listing because its securities have been suspended from quotation for a continuous period of two years

The company has not received sufficient funds to meet the minimum subscription for the capital raising and has determined to close the offers effective immediately. The expiry date of the prospectus is brought forward to today's date, being 27 March 2023. No securities will be issued, and the company will not be accepting any applications. Applications to date will be refunded in accordance with the terms of the offers. The company will not be proceeding with the acquisition of Amplifiy Eyecare Limited, and the various ressolutions wwhich were approved by shareholders at the extraordinary general meeting, save for the consolidation of the company's shares, will not be implemented.

The company releases a supplementary prospectus.

Further to the replacement prospectus, the offer will be extended to 27 March 2023.

The company lodges its Appendix 4D and Half Year Accounts.

The company releases an update on the consolidation of its securities. The resolution to consolidate shares was approved at EGM.

The company releases the results of its meeting.

The company releases its 2023 EGM Runsheet.

The company releases a notice of consolidation of securities. Shareholders get 100 shares for every 1,678 shares presently owned.

The company releses a replacement prospectus: for an offer of up to 40,000,000 Shares (on a post-Consolidation basis) at an issue price of $0.20 per Share to raise up to $8 million (before costs); for an offer of up to 35,000,000 Shares at a deemed issue price of $0.20 per Share to the Vendors as consideration payable by the Company pursuant to the Acquisition. Offers close at 5.00 pm (AEDT) on 6 March 2023 (unless extended). Valid Application Forms must be received before that time.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

The company releases a prospectus for an offer of up to 40,000,000 Shares (on a post-Consolidation basis) at an issue price of $0.20 per Share to raise up to $8 million; for an offer of up to 35,000,000 Shares at a deemed issue price of $0.20 per Share to the Vendors as consideration payable by the Company pursuant to the Acquisition.

The company's extraordinary general meeting will be held at 11.00am (Australian Eastern Daylight Time) on Monday, 20 February 2023 at Level 11, 60 Castlereagh Street, Sydney NSW 2000.

The company releases the results of its meeting.

The company releases its 2022 AGM Runsheet.

The company has signed a conditional share purchase agreement under which it will acquire all of the issued shares in Amplify Eyecare Limited. Amplify operates optometry practices, including the provision of vision diagnostics, vision therapy, surgery, dispensing of spectacle frames, lenses and contact lenses, and develops software services relevant to these services.

The company will hold its AGM at 11.00am (Australian Eastern Daylight Time) on Wednesday, 21 December 2022 at Level 11, 60 Castlereagh Street, Sydney NSW 2000.

The company releases an Updated Corporate Governance Statement.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

In relation to the non-binding agreement to acquire a health care entity, the proposed transaction has progressed, and the Company has applied for in-principle advice in connection with suitability for admission with the ASX. The ASX has advised that there will be no action on removal from the official list until the matter has been considered. CWL is aware of its continuous disclosure obligations under Listing Rule 3.1 and confirms that it is in compliance with its obligations.

The company lodges the following: Appendix 4G and Corporate Governance Statement and Annual Report to shareholders.

The company lodges its Appendix 4E and Preliminary Financial Report.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

The company lodges its Appendix 4D and Half Year Accounts.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

The company releases the results of its meeting.

The company releases its 2021 AGM Runsheet.

The company's AGM will be held at Level 11, 60 Castlereagh Street, Sydney NSW 2000 at 11am Monday 31st January 2022. Please refer to the document for further details.

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

The company releases its Appendix 4G and Corporate Governance Statement.

The company lodges its Appendix 4E and Annual Report.

The company lodges its Appendix 4C - Quarterly.

The company lodges an Appendix 4C - quarterly.

The company lodges its Half Yearly Report and Accounts.

The company releases the 2020 Results of AGM.

The company releases its 2020 AGM Runsheet.

The company lodges its Appendix 4C - quarterly.

CWL is moved into due diligence on the reverse takeover of a fast-growing branded Australian renewable energy storage company. The company's AGM will be held via live webcast at 11am Friday 29th January 2021.

The company lodges its Appendix 4C - quarterly.

The securities of Consolidated Financial Holdings Limited will be suspended from quotation immediately under Listing Rule 17.3. The securities will remain suspended until an update from CWL has been made about the current status of its activities.

we understand that on or about this date the company made a capital return of 11 cents per share

name changed from Chant West Holdings Limited